These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 20062924)

  • 21. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
    Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
    Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism.
    Selby R; Geerts W; Ofosu FA; Craven S; Dewar L; Phillips A; Szalai JP
    Thromb Res; 2009 Jul; 124(3):281-7. PubMed ID: 19041119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism.
    Tappenden KA; Gallimore MJ; Evans G; Mackie IJ; Jones DW
    Br J Haematol; 2007 Oct; 139(1):106-12. PubMed ID: 17854314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin generation in plasma: its assessment via the endogenous thrombin potential.
    Hemker HC; Béguin S
    Thromb Haemost; 1995 Jul; 74(1):134-8. PubMed ID: 8578446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
    Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coagulation factor mutations and thrombosis].
    Aiach M; Alhenc-Gelas M; Borgel D; Emmerich J; Gandrille S; Picard V
    Med Sci (Paris); 2006 Nov; 22(11):985-9. PubMed ID: 17101102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin generation and venous thromboembolism.
    Eichinger S
    Hamostaseologie; 2008 Feb; 28(1-2):37-9. PubMed ID: 18278160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
    Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
    Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL; Welsh CH; Qamar Z; Marlar RA
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of thrombin generation by TFPI in plasma without and with heparin.
    Brodin E; Appelbom H; Osterud B; Hilden I; Petersen LC; Hansen JB
    Transl Res; 2009 Mar; 153(3):124-31. PubMed ID: 19218095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
    Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
    J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
    Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B; Barbay V; Borg JY; Le Cam-Duchez V
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
    Långström S; Wartiovaara-Kautto U; Andersson S; Heikinheimo M; Petäjä J
    Thromb Haemost; 2006 Aug; 96(2):142-8. PubMed ID: 16894456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.
    Dielis AW; Balliël WM; van Oerle R; Hermens WT; Spronk HM; Ten Cate H; Hamulyák K
    Haematologica; 2008 Sep; 93(9):1351-7. PubMed ID: 18641016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.